These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 3494533)

  • 21. Antigen-directed retention of an autoimmune T-cell line.
    Lightman SL; Caspi RR; Nussenblatt RB; Palestine AG
    Cell Immunol; 1987 Nov; 110(1):28-34. PubMed ID: 2960461
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Isolation of retinal lymphocytes in experimental autoimmune uveoretinitis: phenotypic and functional characterization.
    Barton K; Calder VL; Lightman S
    Immunology; 1993 Mar; 78(3):393-8. PubMed ID: 8097489
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cross-reactivity between an HLA-B27-derived peptide and a retinal autoantigen peptide: a clue to major histocompatibility complex association with autoimmune disease.
    Wildner G; Thurau SR
    Eur J Immunol; 1994 Nov; 24(11):2579-85. PubMed ID: 7957552
    [TBL] [Abstract][Full Text] [Related]  

  • 24. EAU in the guinea pig: inhibition of cell-mediated immunity and Ia antigen expression by cyclosporin A.
    Liversidge J; Thomson AW; Sewell HF; Forrester JV
    Clin Exp Immunol; 1987 Sep; 69(3):591-600. PubMed ID: 3478162
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of retinal autoantigens and their peptides on the inhibition of experimental autoimmune uveitis.
    Dua HS; Abrams MS; Barrett JA; Donoso LA
    Eye (Lond); 1992; 6 ( Pt 5)():447-52. PubMed ID: 1286703
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Changes in ocular mast cell numbers and histamine distribution during experimental autoimmune uveitis.
    Lee CH; Lang LS; Orr EL
    Reg Immunol; 1993; 5(2):106-13. PubMed ID: 8217552
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Induction of oral tolerance to S-antigen induced experimental autoimmune uveitis by a uveitogenic 20mer peptide.
    Thurau SR; Chan CC; Suh E; Nussenblatt RB
    J Autoimmun; 1991 Jun; 4(3):507-16. PubMed ID: 1910426
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A combination of inhibiting microglia activity and remodeling gut microenvironment suppresses the development and progression of experimental autoimmune uveitis.
    Zhou J; Yang J; Dai M; Lin D; Zhang R; Liu H; Yu A; Vakal S; Wang Y; Li X
    Biochem Pharmacol; 2020 Oct; 180():114108. PubMed ID: 32569628
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Modulating phenotype and cytokine production of leucocytic retinal infiltrate in experimental autoimmune uveoretinitis following intranasal tolerance induction with retinal antigens.
    Laliotou B; Dick AD
    Br J Ophthalmol; 1999 Apr; 83(4):478-85. PubMed ID: 10434874
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Induction of experimental autoimmune uveoretinitis in Lewis rats with purified recombinant human retinal S-antigen fusion protein.
    Roberts AJ; Kasp E; Stanford M; Dumonde DC; Banga JP
    Eur J Immunol; 1992 Apr; 22(4):951-6. PubMed ID: 1551407
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The use of synthetic peptides in the study of experimental autoimmune uveitis.
    Donoso LA; Gregerson DS; Fling SP; Merryman CF; Sery TW
    Curr Eye Res; 1990; 9 Suppl():155-61. PubMed ID: 1696532
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Experimental autoimmune uveitis (EAU): immunophenotypic analysis of inflammatory cells in chorio retinal lesions.
    Liversidge J; Forrester JV
    Curr Eye Res; 1988 Dec; 7(12):1231-41. PubMed ID: 3229134
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antigen-specific suppressor cells in experimental autoimmune uveitis.
    Rao NA; Atalla L; Fong SL; Chen F; Linker-Israeli M; Steinman L
    Ophthalmic Res; 1992; 24(2):92-8. PubMed ID: 1535119
    [TBL] [Abstract][Full Text] [Related]  

  • 34. S-antigen. Adoptive transfer of experimental autoimmune uveitis following immunization with a small synthetic peptide.
    Merryman CF; Donoso LA; Sery TW; Sciutto E; Bauer A; Shinohara T
    Arch Ophthalmol; 1987 Jun; 105(6):841-3. PubMed ID: 3495257
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intranasal administration of retinal antigens suppresses retinal antigen-induced experimental autoimmune uveoretinitis.
    Dick AD; Cheng YF; Liversidge J; Forrester JV
    Immunology; 1994 Aug; 82(4):625-31. PubMed ID: 7835927
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Suppression of experimental autoimmune uveitis in Lewis rats by oral administration of recombinant Escherichia coli expressing retinal S-antigen.
    Singh VK; Anand R; Sharma K; Agarwal SS
    Cell Immunol; 1996 Sep; 172(2):158-62. PubMed ID: 8964076
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Interleukin 2 production in S-antigen immunized rats and effects of cyclosporine].
    Fujino Y; Okumura A; Nakamura M; Mochizuki M
    Nippon Ganka Gakkai Zasshi; 1986 Dec; 90(12):1646-52. PubMed ID: 3493642
    [No Abstract]   [Full Text] [Related]  

  • 38. Lipid peroxidation in experimental uveitis: sequential studies.
    Goto H; Wu GS; Chen F; Kristeva M; Sevanian A; Rao NA
    Curr Eye Res; 1992 Jun; 11(6):489-99. PubMed ID: 1324132
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of a potent new pathogenic site in human retinal S-antigen which induces experimental autoimmune uveoretinitis in LEW rats.
    Gregerson DS; Merryman CF; Obritsch WF; Donoso LA
    Cell Immunol; 1990 Jun; 128(1):209-19. PubMed ID: 2344622
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Leflunomide: inhibition of S-antigen induced autoimmune uveitis in Lewis rats.
    Robertson SM; Lang LS
    Agents Actions; 1994 Oct; 42(3-4):167-72. PubMed ID: 7879705
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.